Mark L. Fuerst

An online tool for juvenile arthritis, guidelines on childhood lupus, and good news about the response to treatment for ANCA-associated vasculitis

Experts now believe that psoriatic arthritis should be considered a risk factor for cardiovascular diseases, including stroke.

Tumor necrosis factor inhibitors have transformed the treatment of psoriatic arthritis. However, switching TNF inhibitors two or three times is not uncommon.

Epidemiological evidence points to an intimate relationship between intestinal inflammation and joint inflammation, such as psoriatic arthritis.

A new study finds that slightly more than one-third of the patients were adherent to their index biologic and almost half discontinued within 12 months of initiation of therapy.

The prevalence of gout in more affluent countries seems to be increasing in recent decades. Medications, co-morbidities, genetics and other risk factors are to blame.

A consensus definition of a lupus low disease activity state appears to predict improved outcomes among patients with systemic lupus erythematosus.

Rheumatology Network examines common comorbidities in rheumatoid arthritis and their role in limiting mobility.

Repetitive intraarticular corticosteroid injections to the temporomandibular joint do not prevent progressive osseous deformation nor normalize mandibular growth in children with juvenile idiopathic arthritis.

T cell activator associated with psoriatic arthritis but not psoriasis.

Ultrasound diagnosis of tenosynovitis has now been shown to be superior to clinical signs and symptoms (eg, early morning stiffness, symmetrical arthritis, and hand joint arthritis) in predicting early rheumatoid arthritis.

The "Green Berets" of the brain, microglia cells, become hyperactive in fibromyalgia and are key to causing symptoms, said a psychologist and neuroscientist. Finding ways to control them is the key to future treatments, he feels.